SCHEMBL14423151

SCHEMBL14423151

CS(=O)(=O)c1ccc(C(CC2CCC(=O)CC2)C(=O)Nc2cnc(Br)cn2)cc1Cl

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCK P35557 16/20 0.70
KCNH2 Q12809 3/20 0.65
FFAR2 O15552 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2642044 1.00 GCK (0.70) GCKKCNH2FFAR2
SCHEMBL2642046 1.00 GCK (0.70) GCKKCNH2FFAR2
SCHEMBL2665234 1.00 GCK (0.70) GCKKCNH2FFAR2
SCHEMBL2642062 0.95 GCK (0.78) GCKKCNH2
SCHEMBL14423141 0.95 GCK (0.78) GCKKCNH2
SCHEMBL2644707 0.92 KCNH2 (0.76) GCKKCNH2
SCHEMBL2644709 0.92 KCNH2 (0.76) GCKKCNH2
SCHEMBL2642194 0.91 GCK (0.72) GCKKCNH2
SCHEMBL2642075 0.91 GCK (0.72) GCKKCNH2FFAR2
SCHEMBL2642080 0.91 GCK (0.72) GCKKCNH2FFAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1329386-C Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE CO LTD (CH) 2007-08-01 CN claimed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 CN claimed
US-7259166-B2 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators HOFFMANN-LA ROCHE INC. (US) 2007-08-21 US disclosed
CN-1329386-C Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE CO LTD (CH) 2007-08-01 CN disclosed
EP-1501815-B1 SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2006-11-22 EP disclosed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 CN disclosed
WO-2003095438-A9 SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2004-12-23 WO disclosed